BioCentury
ARTICLE | Company News

InSite to license antibiotics from SSP

December 13, 2000 8:00 AM UTC

ISV signed a letter of intent to license SS732 and SS734 second generation fluoroquinolone antibiotics for ophthalmic use from SSP (Tokyo, Japan). ISV will use its DuraSite technology to develop an op...